+61 3 9828 1400
admin@ausbiotech.org
Member Login
Search
Member Login
Home
About AusBiotech
About us
Team
Board
Committees
Contact us
Biotechnology Industry
Overview
Directories
Careers
Events
Conferences
Event calendar
State events
BiotechTalks - AusBiotech Webcasts
Investment events
International events
AusEvents™
BiotechTalks Library - member benefit
Sector events
Member Services
Member benefits
Become a member
Student membership
Business Solutions Programme
Investing in Biotech
Investment events
For life sciences companies
For life sciences investors
Industry highlights
Programmes
AusMedtech
AusAg & Foodtech
International engagement
Biotherapeutics
Clinical trials
Regenerative Medicines Catalyst Project
Biotech board enhancement
Global Investment Programme
Newsroom
Media Releases
AusBiotech Updates
Biotech Dispatch
Publications
Photo galleries
Policy & Advocacy
Industry Position Survey
Policy positions
Submissions
Reports
Home
Newsroom
Newsroom
.
Prescient to resume clinical trial of PTX- 200 in ovarian cancer
7 Nov 2017
